Relationship between neuropsychiatric disorders and cognitive and behavioural change in MND

Caroline A McHutchison1,2,3, Danielle Jane Leighton2,4, Andrew McIntosh3,5

  • 1Human Cognitive Neurosciences, Department of Psychology, The University of Edinburgh, Edinburgh, UK Caroline.McHutchison@ed.ac.uk.

Abstract

Insights

A history of neuropsychiatric disorders in motor neuron disease (MND) patients and their families is linked to cognitive and behavioral changes. These findings suggest a connection between MND, frontotemporal dementia, and neuropsychiatric conditions.

Area of Science:

  • Neurology
  • Psychiatry
  • Genetics

Background:

  • Motor neuron disease (MND) is a progressive neurodegenerative disorder.
  • Cognitive and behavioral impairments are increasingly recognized in MND.
  • The role of neuropsychiatric history in predicting these impairments requires further investigation.

Purpose of the Study:

  • To investigate the association between patient neuropsychiatric history, medication, and family history of neuropsychiatric disorders with cognitive and/or behavioral impairment in motor neuron disease (MND).

Main Methods:

  • Population-based study using the CARE-MND register (2015-2018).
  • Included 305 people with MND (pwMND) assessed with the Edinburgh Cognitive and Behavioural ALS Screen.
  • Extracted data on patient neuropsychiatric, medication, and family history.

Main Results:

  • 19.7% of pwMND had a neuropsychiatric disorder; 15.58% had a family history.
  • Patient premorbid mood disorders correlated with increased apathy.
  • Family history of neuropsychiatric disorders was linked to poorer visuospatial scores, MND with behavioral impairment (MNDbi), and MND-frontotemporal dementia (MND-FTD).
  • Family history of mood and neurotic disorders showed associations with poorer cognitive scores and MND-FTD.

Conclusions:

  • Neuropsychiatric disorders in patients and families are associated with cognitive/behavioral changes post-MND diagnosis.
  • These associations often occur independently of MND-FTD and C9orf72 status.
  • Findings support an overlap between MND, frontotemporal dementia, and neuropsychiatric disorders, especially mood disorders.

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.6K
Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
2.4K
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.0K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
890
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.6K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.5K